Ceftazidime-avibactam: Combination therapy versus monotherapy in the challenge of pneumonia caused by carbapenem-resistant Klebsiella pneumoniae

This research focused on evaluating the clinical results of patients suffering from pneumonia caused by carbapenem-resistant Klebsiella pneumoniae (CRKP), who received treatment with either ceftazidime–avibactam (CZA) alone or in combination with other antibiotics. From January 2020 to December 2023...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chang-wei Liu, Qiang Chen, Nan Ding, Li-fen Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-08-01
coleção:	Heliyon
Assuntos:	Ceftazidime-avibactam Monotherapy Combination therapy Pneumonia Carbapenem-resistant Klebsiella pneumoniae
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2405844024117884
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!